Corticosteroid
Using inhaled corticosteroids for 24-plus months ups diabetes, osteoporosis risk in COPD
Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, pneumonia, cataracts and fractures than those with less than 4 months’ use, according to study data.
Mortality risks increase with chronic spontaneous urticaria
Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, compared with a control group, according to a study published in The Journal of Allergy and Clinical Immunology.
83.1% of children prescribed respiratory medication in first 10 years
Among children born in France, 83.1% had been prescribed a respiratory medication during the ages of 0 through 10 years, according to results published in Respiratory Medicine.
Systemic Therapies
Six-month asthma control score on mepolizumab predicts remission in eosinophilic asthma
Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was deemed “best predictor” of 12-month remission in patients with severe eosinophilic asthma, according to study data.
Patients with severe eosinophilic asthma, prior biologic use benefit from benralizumab
Among adults with severe eosinophilic asthma and previous biologic use, benralizumab for 48 weeks aided in reducing exacerbations and improving asthma symptom control, according to results published in European Respiratory Journal.
Fewer than 50% of patients with sarcoidosis treated within year of diagnosis
Less than half of patients with sarcoidosis had been treated by the 1-year mark since being diagnosed with the condition, according to results published in CHEST.
New inhaled COPD maintenance medication prescriptions rise in recent years
BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST Annual Meeting.
Maintaining asthma control lessens risk for asthma complications in pregnant patients
BOSTON — Asthma control during pregnancy lowers the risk for complications, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Concomitant use of common medications does not significantly affect UC induction therapy
Baseline concomitant exposure to commonly used medications, such as corticosteroids and 5-aminosalicylates, did not significantly affect clinical and endoscopic outcomes during induction therapy in ulcerative colitis, data analysis showed.